Immuron (IMRN) Cash & Current Investments (2016 - 2025)

Immuron (IMRN) posted quarterly Cash & Current Investments of $28.3 billion for Q3 2025, up 24281014.48% year-on-year from N/an in Q3 2024, and up 1415879.98% on a QoQ basis from $2.0 million in Q2 2025.

Immuron (IMRN) Cash & Current Investments (2016 - 2025) Analysis & Trends

Immuron (IMRN) has reported Cash & Current Investments for 10 consecutive years, with $28.3 billion the latest figure, recorded in Q3 2025.

  • Quarterly Cash & Current Investments rose 24281014.48% year-over-year to $28.3 billion in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $28.3 billion (up 24281014.48% YoY) and the FY2025 annual result came in at $11.7 million, down 32.07% from the prior year.
  • Cash & Current Investments advanced to $28.3 billion in Q3 2025 per IMRN's latest filing, from $2.0 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for IMRN reached as high as $28.3 billion in Q3 2025 and fell as low as $116573.2 in Q3 2024.
  • A 5-year average of $2.0 billion and a median of $12.7 million in 2023 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2023 — Cash & Current Investments sank 98.9% — and 2025, when it jumped 24281014.48%.
  • Year by year, Cash & Current Investments stood at $17.7 million in 2021, then retreated by 11.73% to $15.6 million in 2022, then declined by 14.67% to $13.3 million in 2023, then tumbled by 38.21% to $8.2 million in 2024, then soared by 343715.72% to $28.3 billion in 2025.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $28.3 billion, $2.0 million, and $8.2 million for Q3 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 283.54 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 61.40 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 5.18 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Immuron 258.65 Mn -28.05 Bn - 28.31 Bn

Historic Data

Download Data
DateValue
Sep 2, 2025 28.31 Bn
Jun 30, 2025 2.00 Mn
Dec 31, 2024 8.23 Mn
Sep 9, 2024 116,573.15
Jun 30, 2024 8.23 Mn
Dec 31, 2023 13.32 Mn
Sep 28, 2023 12.12 Mn
Aug 30, 2023 171,597.64
Jun 30, 2023 13.41 Mn
Dec 31, 2022 15.61 Mn
Aug 31, 2022 15.61 Mn
Jun 30, 2022 15.61 Mn
Dec 31, 2021 17.69 Mn
Jun 30, 2021 2.74 Mn
Dec 31, 2020 264,447.68
Sep 1, 2020 5.12 Mn
Jun 30, 2020 2.30 Mn
Dec 31, 2019 5.12 Mn
Jun 30, 2019 5.12 Mn
Dec 31, 2018 4.73 Mn